• Biologie

  • Progression et métastases

  • Sein

Tspan8 is expressed in breast cancer and regulates E-cadherin / catenin signalling and metastasis accompanied by increased circulating extracellular vesicles

Menée in vitro et sur un modèle murin de cancer mammaire, cette étude met en évidence l'expression de la protéine Tspan8 dans les cellules cancéreuses primitives et les métastases, puis démontre le rôle de cette protéine dans la régulation de la voie de signalisation de la cadhérine E / caténine et la libération des vésicules extracellulaires

Tspan8 exhibits a functional role in many cancer types including pancreatic, colorectal, oesophagus carcinoma and melanoma. We present a first study on the expression and function of Tspan8 in breast cancer. Tspan8 protein was present in the majority of human primary breast cancer lesions and metastases in the brain, bone, lung, and liver. In a syngeneic rat breast cancer model, Tspan8+ tumours formed multiple liver and spleen metastases, while Tspan8‐ tumours exhibited a significantly diminished ability to metastasize, indicating a role of Tspan8 in metastases. Addressing the underlying molecular mechanisms, we discovered that Tspan8 can mediate upregulation of E-cadherin and down-regulation of Twist, p120-catenin, and

β

‐catenin target genes accompanied by the change of cell phenotype, resembling the mesenchymal‐epithelial transition. Furthermore, Tspan8+ cells exhibited enhanced cell-cell adhesion, diminished motility, and decreased sensitivity to irradiation. As a regulator of the content and function of extracellular vesicles (EVs), Tspan8 mediated a several‐fold increase in EV number in cell culture and the circulation of tumour‐bearing animals. We observed increased protein levels of E-cadherin and p120-catenin in these EVs; furthermore, Tspan8 and p120‐catenin were co‐immunoprecipitated, indicating that they may interact with each other. Altogether, our findings show presence of Tspan8 in breast cancer primary lesion and metastases and indicate its role as a regulator of cell behaviour and EV release in breast cancer.

The Journal of Pathology 2019

Voir le bulletin